Forecast Of The Day: Intuitive Surgical’s Average Instrument & Accessory Sales
What?
Trefis expects Intuitive Surgical (NASDAQ: ISRG) Average Instrument & Accessory Spend per unit of its installed base of da Vinci surgical systems to increase from levels of around $424,000 in 2020 to $437,000 in 2021 and $450,000 in 2022.
Why?
- Should You Pick Intuitive Surgical Stock At $375 After An Upbeat Q4?
- Is Intuitive Surgical Stock A Pick After A 9% Fall In A Month Amid Mixed Q3?
- Procedure Volume Growth To Drive Intuitive Surgical’s Q3
- With 2x Potential Returns Is DexCom A Better Pick Over Intuitive Surgical?
- Here’s What To Expect From Intuitive Surgical’s Q2
- Should You Buy Intuitive Surgical Stock Over MDT?
Demand is likely to rise, as elective surgeries increase following the Covid-19 lockdowns and also as the company sees higher sales of new supplementary products.
So What?
Instruments and Accessory sales are the biggest driver of Intuitive Surgical’s revenues and profits. As sales recover in 2021, it should bode well for the company’s bottom line.
See Our Complete Analysis For Intuitive Surgical
While we think Intuitive Surgical stock looks slightly undervalued, it is helpful to know how its peers stack up. Intuitive Surgical Stock Comparison With Peers summarizes how ISRG compares against peers on metrics that matter. You can find more such useful comparisons on Peer Comparisons.
See all Trefis Price Estimates and Download Trefis Data here
What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams | Product, R&D, and Marketing Teams